Haloperidol Decanoate (Gland Pharma Limited)


Welcome to the PulseAid listing for the Haloperidol Decanoate drug offered from Gland Pharma Limited. This Typical Antipsychotic [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Gland Pharma Limited
NON-PROPRIETARY NAME: Haloperidol Decanoate
SUBSTANCE NAME: HALOPERIDOL DECANOATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Typical Antipsychotic [EPC]
ROUTE: INTRAMUSCULAR
DOSAGE FORM: INJECTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2017-05-18
END MARKETING DATE: 0000-00-00


Haloperidol Decanoate HUMAN PRESCRIPTION DRUG Details:

Item DescriptionHaloperidol Decanoate from Gland Pharma Limited
LABELER NAME: Gland Pharma Limited
DEA SCHEDULE:
ACTIVE STRENGTH: 50(mg/mL)
START MARKETING DATE: 2017-05-18
END MARKETING DATE: 0000-00-00
PRODUCT ID: 68083-137_4f1755c1-55da-4016-b943-da9913686822
PRODUCT NDC: 68083-137
APPLICATION NUMBER: ANDA205241

Other HALOPERIDOL DECANOATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Amneal-Agila, LLCHaloperidol Decanoate
Fresenius Kabi USA, LLCHaloperidol Decanoate
Gland Pharma LimitedHaloperidol Decanoate
Janssen Pharmaceuticals, Inc.Haldol Decanoate
Mylan Institutional LLCHaloperidol Decanoate
Patriot Pharmaceuticals LLCHaloperidol Decanoate
Teva Parenteral Medicines, Inc.Haloperidol Decanoate
TYA PharmaceuticalsHaloperidol Decanoate